New Cancer Treatment For Australian Dogs With APVMA Approval Of Qbiotics' Stelfonta®
- Written by PR Newswire
- STELFONTA® (tigilanol tiglate) is now approved by the Australian Pesticides and Veterinary Medicines Authority (APVMA) for the treatment of canine non-metastatic mast cell tumours (MCT).
- APVMA approval follows marketing authorisation (registration) and launch of STELFONTA® in the major companion animal markets of the US, Europe, and the Uni...
